The historical rank and industry rank for IDEAYA Biosciences's Pretax Margin % or its related term are showing as below:
FRA:30J'
s Pretax Margin % Range Over the Past 10 Years
Min: -3942.31 Med: -178.1 Max: -115.17
Current: -3942.31
FRA:30J's Pretax Margin % is ranked worse than 86.34% of 1003
companies
in the Biotechnology industry
Industry Median: -134.73
vs FRA:30J: -3942.31
IDEAYA Biosciences Pretax Margin % Historical Data
The historical data trend for IDEAYA Biosciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IDEAYA Biosciences's Pretax Margin %
For the Biotechnology subindustry, IDEAYA Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEAYA Biosciences's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IDEAYA Biosciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where IDEAYA Biosciences's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
IDEAYA Biosciences Pretax Margin % Related Terms
Thank you for viewing the detailed overview of IDEAYA Biosciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:30J has been successfully added to your 